Fibroblast growth factor 23 concentrations in humoral hypercalcemia of malignancy and hyperparathyroidism |
| |
Authors: | Singh Ravinder J Kumar Rajiv |
| |
Affiliation: | Division of Clinical Biochemistry and Immunology, Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minn 55905, USA. |
| |
Abstract: | OBJECTIVE: To determine whether fibroblast growth factor 23 (FGF 23) concentrations are increased in the serum of patients with humoral hypercalcemia of malignancy and in those with hyperparathyroidism. PATIENTS AND METHODS: Serum samples from patients with hypercalcemia and documented elevations of parathyroid hormone-related protein or parathyroid hormone levels were examined for FGF 23 concentrations. Specimens from healthy age-matched controls were evaluated to establish a reference range for FGF 23. RESULTS: Mean +/- SEM concentrations of FGF 23 were elevated in the 7 patients with humoral hypercalcemia of malignancy (385 +/- 134 relative unit [RU]/mL) compared with 11 healthy controls (43.9 +/- 5.8 RU/mL; P = .005). In the 11 patients with hyperparathyroidism, FGF 23 concentrations were increased (mean +/- SEM 86.6 +/- 228 RU/mL), but the increases were not statistically significant. The increases in FGF 23 in these disorders did not correlate with changes in serum phosphate or 1alpha,25-dihydroxyvitamin D levels. CONCLUSION: Levels of FGF 23 are elevated in patients with tumors associated with humoral hypercalcemia of malignancy. The precise cause of such elevations requires further investigation. |
| |
Keywords: | |
本文献已被 ScienceDirect PubMed 等数据库收录! |
|